<?xml version="1.0" encoding="ISO-8859-1" ?>
<?xml-stylesheet title="XSL_formatting" type="text/xsl" href="/css/xsl.xsl"?> 
<rss version="2.0">
<channel>
<title><![CDATA[ Feedzilla: Top 20 news stories:  Category: 'science' - Sub-category: 'Biotechnologies'  ]]> </title>
<description><![CDATA[ Add free content to your site and blog. ]]> </description>
<link>http://www.feedzilla.com</link>
<language>en</language>
<lastBuildDate>Wed, 9 Jul 2008 4:54:13 AM EST</lastBuildDate>
<image>
<title>Read News. Syndicate News.</title>
<url>http://www.feedzilla.com/img/logo.gif</url>
<link>http://www.feedzilla.com</link>
</image>
<item>
<title>Sponsored Link</title>
<description><![CDATA[ <a href="http://www.pheedo.com/click.phdo?x=e6d82897ef92488b8baa486cee2c7bb5&u=1309045413788"><img src="http://www.pheedo.com/img.phdo?x=e6d82897ef92488b8baa486cee2c7bb5&u=1309045413788" border="0"/></a> <img src="http://track.feedzilla.com/?type=imp&tag=feed" border="0" style="width:1px;height:1px;"> ]]></description>
<link><![CDATA[ http://www.pheedo.com/click.phdo?x=e6d82897ef92488b8baa486cee2c7bb5&u=1309045413788 ]]></link>
<pubDate><![CDATA[ Wed, 9 Jul 2008 4:54:13 AM EST ]]></pubDate>
</item>
<item>
<title><![CDATA[Monogram to roll out breast cancer test, compete with Invitrogen]]></title>
<description><![CDATA[Monogram Biosciences Inc. said Tuesday that it will make its HERmark breast cancer assay available to doctors throughout the United States starting July 15.  (MGRM) (IVGN)<script language="javascript">document.write("<img width=1 height=1 src='http://www.feedzilla.com/tools/tracking_pixel.asp?tool=feed_free&prov=&cat=science&cat2=Biotechnologies&kw=&ip=38.103.63.16&ref='>");</script><BR>Brought to you by <a href='http://www.feedzilla.com' title='Add free content to your site and blog.'>Feedzilla.com</a>]]></description>
<link><![CDATA[ http://feeds.bizjournals.com/~r/vertical_32/~3/330236635/daily27.html]]></link>
<pubDate>Tue, 08 Jul 2008 22:31:44 GMT</pubDate>
</item>
<item>
<title><![CDATA[Johnson &amp; Johnson shifting 260 jobs to Centocor]]></title>
<description><![CDATA[Johnson &amp; Johnson said Tuesday it is moving about 260 positions from its Ortho Biotech unit to Centocor in Horsham, Pa.  (JNJ)<script language="javascript">document.write("<img width=1 height=1 src='http://www.feedzilla.com/tools/tracking_pixel.asp?tool=feed_free&prov=&cat=science&cat2=Biotechnologies&kw=&ip=38.103.63.16&ref='>");</script><BR>Brought to you by <a href='http://www.feedzilla.com' title='Add free content to your site and blog.'>Feedzilla.com</a>]]></description>
<link><![CDATA[ http://feeds.bizjournals.com/~r/vertical_32/~3/330166977/daily31.html]]></link>
<pubDate>Tue, 08 Jul 2008 21:14:04 GMT</pubDate>
</item>
<item>
<title><![CDATA[Biotech company moves HQ to Broomfield]]></title>
<description><![CDATA[Biotechnology company Arca Biopharma Inc. moved its headquarters from Denver to a new building next to the Broomfield Event Center on U.S. 36, the company announced Tuesday.<script language="javascript">document.write("<img width=1 height=1 src='http://www.feedzilla.com/tools/tracking_pixel.asp?tool=feed_free&prov=&cat=science&cat2=Biotechnologies&kw=&ip=38.103.63.16&ref='>");</script><BR>Brought to you by <a href='http://www.feedzilla.com' title='Add free content to your site and blog.'>Feedzilla.com</a>]]></description>
<link><![CDATA[ http://feeds.bizjournals.com/~r/vertical_32/~3/330166978/daily18.html]]></link>
<pubDate>Tue, 08 Jul 2008 20:50:56 GMT</pubDate>
</item>
<item>
<title><![CDATA[Pipex Pharmaceuticals, Inc.: Pipex Pharmaceuticals to Host Conference Call at 10:15am ET Wednesday July 9th to Discuss Phase II Clinical Trial Results in Dry Age-Related Macular Degeneration (AMD) With Oral Z-Monocys]]></title>
<description><![CDATA[ANN ARBOR, MI (MARKET WIRE)  Pipex Pharmaceuticals, Inc. (AMEX: PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of central nervous systems and autoimmune diseases, today announced that it will hold a conference call on Wednesday, July 9, 2008 at 10:15 a.m. ET to discuss the results of its double-blind, placebo-controlled phase II clinical trial results in the treatment of dry age-related macular degeneration (AMD) with oral Z-Monocys. Nicholas Stergis, Vice Chairman and Chief Executive Officer of Pipex, will host the call.<script language="javascript">document.write("<img width=1 height=1 src='http://www.feedzilla.com/tools/tracking_pixel.asp?tool=feed_free&prov=&cat=science&cat2=Biotechnologies&kw=&ip=38.103.63.16&ref='>");</script><BR>Brought to you by <a href='http://www.feedzilla.com' title='Add free content to your site and blog.'>Feedzilla.com</a>]]></description>
<link><![CDATA[ http://www2.marketwire.com/mw/release_html_b1?release_id=414058&tsource=3]]></link>
<pubDate>Tue, 8 Jul 2008 19:54:00 GMT</pubDate>
</item>
<item>
<title><![CDATA[Covalon Technologies Ltd.: Covalon Achieves Significant Progress in Development Agreement with One of the World's Largest Vascular Access Companies]]></title>
<description><![CDATA[MISSISSAUGA, ONTARIO (MARKET WIRE)  Covalon Technologies Ltd. (TSX VENTURE: COV) is pleased to announce that it has reached a significant milestone in its research as part of a Development Agreement with one of the world's largest vascular access device companies.<script language="javascript">document.write("<img width=1 height=1 src='http://www.feedzilla.com/tools/tracking_pixel.asp?tool=feed_free&prov=&cat=science&cat2=Biotechnologies&kw=&ip=38.103.63.16&ref='>");</script><BR>Brought to you by <a href='http://www.feedzilla.com' title='Add free content to your site and blog.'>Feedzilla.com</a>]]></description>
<link><![CDATA[ http://www2.marketwire.com/mw/release_html_b1?release_id=414012&tsource=3]]></link>
<pubDate>Tue, 8 Jul 2008 17:47:00 GMT</pubDate>
</item>
<item>
<title><![CDATA[PharmEng International Inc.: PharmEng Receives Establishment License From Health Canada for New Facility in Sydney, Nova Scotia]]></title>
<description><![CDATA[TORONTO, ONTARIO (MARKET WIRE)  PharmEng International Inc. (''PharmEng'') (TSX VENTURE: PII), today announced that its wholly owned subsidiary, Keata Pharma Inc. (''Keata''), received a drug establishment license on June 26, 2008 for its manufacturing facility located in Sydney, Nova Scotia. The establishment license was issued after a Good Manufacturing Practices (GMP) inspection was conducted under the authority of the Food and Drugs Act to verify compliance with the applicable regulations. The inspection concluded favourably on June 13,2008. The establishment license is for the manufacturing, testing and packaging of the<script language="javascript">document.write("<img width=1 height=1 src='http://www.feedzilla.com/tools/tracking_pixel.asp?tool=feed_free&prov=&cat=science&cat2=Biotechnologies&kw=&ip=38.103.63.16&ref='>");</script><BR>Brought to you by <a href='http://www.feedzilla.com' title='Add free content to your site and blog.'>Feedzilla.com</a>]]></description>
<link><![CDATA[ http://www2.marketwire.com/mw/release_html_b1?release_id=413954&tsource=3]]></link>
<pubDate>Tue, 8 Jul 2008 16:00:00 GMT</pubDate>
</item>
<item>
<title><![CDATA[VIVALIS: VIVALIS GRANTS RESEARCH LICENCE TO ACAMBIS TO EVALUATE E B66(R) CELL LINE FOR VIRAL VACCINES PRODUCTION]]></title>
<description><![CDATA[NANTES, FRANCE and CAMBRIDGE, MA (MARKET WIRE)  VIVALIS GRANTS RESEARCH LICENCE TO ACAMBIS<script language="javascript">document.write("<img width=1 height=1 src='http://www.feedzilla.com/tools/tracking_pixel.asp?tool=feed_free&prov=&cat=science&cat2=Biotechnologies&kw=&ip=38.103.63.16&ref='>");</script><BR>Brought to you by <a href='http://www.feedzilla.com' title='Add free content to your site and blog.'>Feedzilla.com</a>]]></description>
<link><![CDATA[ http://www2.marketwire.com/mw/release_html_b1?release_id=413944&tsource=3]]></link>
<pubDate>Tue, 8 Jul 2008 15:43:00 GMT</pubDate>
</item>
<item>
<title><![CDATA[Sen. Bruno won't finish term]]></title>
<description><![CDATA[Former Senate Majority Leader Joseph Bruno says he won't finish out his term.  (GE)<script language="javascript">document.write("<img width=1 height=1 src='http://www.feedzilla.com/tools/tracking_pixel.asp?tool=feed_free&prov=&cat=science&cat2=Biotechnologies&kw=&ip=38.103.63.16&ref='>");</script><BR>Brought to you by <a href='http://www.feedzilla.com' title='Add free content to your site and blog.'>Feedzilla.com</a>]]></description>
<link><![CDATA[ http://feeds.bizjournals.com/~r/vertical_32/~3/329888552/daily12.html]]></link>
<pubDate>Tue, 08 Jul 2008 15:01:03 GMT</pubDate>
</item>
<item>
<title><![CDATA[Eniva VIBE(R) Nutraceutical Tested at Linus Pauling Micronutrient Research Institute and Found ...]]></title>
<description><![CDATA[[NEWS]  MINNEAPOLIS, July 3 /PRNewswire/ &#8212; The Eniva Research Group has released results from aboratory testing by the world-famous Linus Pauling Micronutrient Research Institute at Oregon State University which demonstrated the Eniva Health Supplement VIBE&#174; possessed DNA protective anti-mutagenic activity for human cells. This third party testing was performed as part of an ongoing investigative effort to further identify mechanisms by which the Eniva VIBE nutraceutical impacts human health.      Chief &#8230;<script language="javascript">document.write("<img width=1 height=1 src='http://www.feedzilla.com/tools/tracking_pixel.asp?tool=feed_free&prov=&cat=science&cat2=Biotechnologies&kw=&ip=38.103.63.16&ref='>");</script><BR>Brought to you by <a href='http://www.feedzilla.com' title='Add free content to your site and blog.'>Feedzilla.com</a>]]></description>
<link><![CDATA[ http://www.lifesciencesworld.com/news/view/75389]]></link>
<pubDate>Thu, 03 Jul 2008 17:12:00 -0400</pubDate>
</item>
<item>
<title><![CDATA[Rising Medical Solutions, Inc. Expands Its California Managed Care Services to Include ...]]></title>
<description><![CDATA[[NEWS]  CHICAGO, July 3 /PRNewswire/ &#8212; Rising Medical Solutions, Inc. (Rising), a leading medical cost containment and care management organization, has extended its offerings in California to include Utilization Review (UR) services in addition to its Medical Bill Review and Medical Provider Network (MPN) services in the State. This product line expansion is part of a corporate wide effort to provide a full-service managed care program in the California market for Rising&#8217;s existing and growing customer bas&#8230;<script language="javascript">document.write("<img width=1 height=1 src='http://www.feedzilla.com/tools/tracking_pixel.asp?tool=feed_free&prov=&cat=science&cat2=Biotechnologies&kw=&ip=38.103.63.16&ref='>");</script><BR>Brought to you by <a href='http://www.feedzilla.com' title='Add free content to your site and blog.'>Feedzilla.com</a>]]></description>
<link><![CDATA[ http://www.lifesciencesworld.com/news/view/75370]]></link>
<pubDate>Thu, 03 Jul 2008 14:00:00 -0400</pubDate>
</item>
<item>
<title><![CDATA[Senesco Chooses VGXI to Produce Factor 5A Plasmid]]></title>
<description><![CDATA[[NEWS]  NEW BRUNSWICK, N.J., July 3 /PRNewswire-FirstCall/ &#8212; Senesco Technologies, Inc. (&#8220;Senesco&#8221; or the &#8220;Company&#8221;) (Amex: SNT) announced today that it has contracted with VGXI, Inc. (The Woodlands, TX) (&#8220;VGXI&#8221;) to supply the plasmid portion of the Company&#8217;s combination therapy consisting of the Factor 5A gene and siRNA against Factor 5A.      Senesco has previously reported positive preclinical in vivo results using its combination siRNA and plasmid against subcutaneous multiple myeloma tumors in immunod&#8230;<script language="javascript">document.write("<img width=1 height=1 src='http://www.feedzilla.com/tools/tracking_pixel.asp?tool=feed_free&prov=&cat=science&cat2=Biotechnologies&kw=&ip=38.103.63.16&ref='>");</script><BR>Brought to you by <a href='http://www.feedzilla.com' title='Add free content to your site and blog.'>Feedzilla.com</a>]]></description>
<link><![CDATA[ http://www.lifesciencesworld.com/news/view/75359]]></link>
<pubDate>Thu, 03 Jul 2008 12:00:00 -0400</pubDate>
</item>
<item>
<title><![CDATA[Mylan Announces Tentative FDA Approval for Generic Version of Antibiotic Zyvox(R) Tablets]]></title>
<description><![CDATA[[NEWS]  PITTSBURGH, July 3 /PRNewswire-FirstCall/ &#8212; Mylan Inc. (NYSE: MYL) today announced that its subsidiary, Mylan Pharmaceuticals Inc., has received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Linezolid Tablets, 600 mg.      Linezolid Tablets, an antibiotic, are the generic version of Pharmacia and Upjohn&#8217;s Zyvox&#174; Tablets, which had U.S. sales of approximately $422 million for the 12 months ending March 31, 2008, according to&#8230;<script language="javascript">document.write("<img width=1 height=1 src='http://www.feedzilla.com/tools/tracking_pixel.asp?tool=feed_free&prov=&cat=science&cat2=Biotechnologies&kw=&ip=38.103.63.16&ref='>");</script><BR>Brought to you by <a href='http://www.feedzilla.com' title='Add free content to your site and blog.'>Feedzilla.com</a>]]></description>
<link><![CDATA[ http://www.lifesciencesworld.com/news/view/75358]]></link>
<pubDate>Thu, 03 Jul 2008 12:00:00 -0400</pubDate>
</item>
<item>
<title><![CDATA[Monkeys control robotic arm with brain-machine interface]]></title>
<description><![CDATA[Researchers report in Nature that that tiny sensors implanted in the brains of two monkeys allow primates to control a robotic arm with just their thoughts.<script language="javascript">document.write("<img width=1 height=1 src='http://www.feedzilla.com/tools/tracking_pixel.asp?tool=feed_free&prov=&cat=science&cat2=Biotechnologies&kw=&ip=38.103.63.16&ref='>");</script><BR>Brought to you by <a href='http://www.feedzilla.com' title='Add free content to your site and blog.'>Feedzilla.com</a>]]></description>
<link><![CDATA[ http://www.bioethics.net/News/?id=5611]]></link>
<pubDate>Wed, 28 May 2008 11:12:53 EDT</pubDate>
</item>
<item>
<title><![CDATA[British MPs keep path open for animal-human embryos]]></title>
<description><![CDATA[The House of Commons voted down an amendment to the Human Embryology and Fertilisation Bill that would have banned the embryos.  An amendment to ban ''savior siblings'' also went down.<script language="javascript">document.write("<img width=1 height=1 src='http://www.feedzilla.com/tools/tracking_pixel.asp?tool=feed_free&prov=&cat=science&cat2=Biotechnologies&kw=&ip=38.103.63.16&ref='>");</script><BR>Brought to you by <a href='http://www.feedzilla.com' title='Add free content to your site and blog.'>Feedzilla.com</a>]]></description>
<link><![CDATA[ http://www.bioethics.net/News/?id=5595]]></link>
<pubDate>Mon, 19 May 2008 10:03:46 EDT</pubDate>
</item>
<item>
<title><![CDATA[Gene therapy shows promise for neurological condition]]></title>
<description><![CDATA[Researchers report in the journal Human Gene Therapy that injections of adenovirus carrying corrected forms of a gene associated with Batten's Disease have slowed the progression of the condition.  The researchers say the results provide hope that gene therapy could be used to treat other neurological diseases.<script language="javascript">document.write("<img width=1 height=1 src='http://www.feedzilla.com/tools/tracking_pixel.asp?tool=feed_free&prov=&cat=science&cat2=Biotechnologies&kw=&ip=38.103.63.16&ref='>");</script><BR>Brought to you by <a href='http://www.feedzilla.com' title='Add free content to your site and blog.'>Feedzilla.com</a>]]></description>
<link><![CDATA[ http://www.bioethics.net/News/?id=5585]]></link>
<pubDate>Thu, 15 May 2008 09:31:46 EDT</pubDate>
</item>
<item>
<title><![CDATA[Venter: we're creating microbes that will turn CO2 into fuel]]></title>
<description><![CDATA[Venter says his team is re-engineering already-existing organisms for the task, not creating one from scratch.<script language="javascript">document.write("<img width=1 height=1 src='http://www.feedzilla.com/tools/tracking_pixel.asp?tool=feed_free&prov=&cat=science&cat2=Biotechnologies&kw=&ip=38.103.63.16&ref='>");</script><BR>Brought to you by <a href='http://www.feedzilla.com' title='Add free content to your site and blog.'>Feedzilla.com</a>]]></description>
<link><![CDATA[ http://www.bioethics.net/News/?id=5413]]></link>
<pubDate>Thu, 28 Feb 2008 10:46:51 EST</pubDate>
</item>
<item>
<title><![CDATA[Transparent Fish New Cancer Bioassay Tool]]></title>
<description><![CDATA[The zebrafish is a common test organism for measuring aquatic toxicity. Now, we have a new use for this powerful bioassay tool. Recently, a transparent zebrafish has been bred for...<script language="javascript">document.write("<img width=1 height=1 src='http://www.feedzilla.com/tools/tracking_pixel.asp?tool=feed_free&prov=&cat=science&cat2=Biotechnologies&kw=&ip=38.103.63.16&ref='>");</script><BR>Brought to you by <a href='http://www.feedzilla.com' title='Add free content to your site and blog.'>Feedzilla.com</a>]]></description>
<link><![CDATA[ http://biotech.about.com/b/2008/07/02/transparent-fish-new-cancer-bioassay-tool.htm]]></link>
<pubDate></pubDate>
</item>
<item>
<title><![CDATA[Bioassay Glossary]]></title>
<description><![CDATA[When you perform a bioassay for measuring titer of an antibody, or specific activity of a protein, are you more concerned with precision or accuracy? Are you replicates real or...<script language="javascript">document.write("<img width=1 height=1 src='http://www.feedzilla.com/tools/tracking_pixel.asp?tool=feed_free&prov=&cat=science&cat2=Biotechnologies&kw=&ip=38.103.63.16&ref='>");</script><BR>Brought to you by <a href='http://www.feedzilla.com' title='Add free content to your site and blog.'>Feedzilla.com</a>]]></description>
<link><![CDATA[ http://biotech.about.com/b/2008/07/02/bioassay-glossary.htm]]></link>
<pubDate></pubDate>
</item>
<item>
<title><![CDATA[Drug Development Threatened by Wary Investors]]></title>
<description><![CDATA[An unnamed survey making news last week was reported to have shown that, of 484 biotech and pharmaceutical executives, 90% believe funding for startups and early stages of new drug...<script language="javascript">document.write("<img width=1 height=1 src='http://www.feedzilla.com/tools/tracking_pixel.asp?tool=feed_free&prov=&cat=science&cat2=Biotechnologies&kw=&ip=38.103.63.16&ref='>");</script><BR>Brought to you by <a href='http://www.feedzilla.com' title='Add free content to your site and blog.'>Feedzilla.com</a>]]></description>
<link><![CDATA[ http://biotech.about.com/b/2008/06/24/drug-development-threatened-by-wary-investors.htm]]></link>
<pubDate></pubDate>
</item>
<item>
<title><![CDATA[Applications for Nanomedical Research]]></title>
<description><![CDATA[Nanoscience is a diverse, multi-disciplined field incorporating the laws of physics, chemistry, biology and math. The boundaries of biomedical research are being stretched by the use of nanotechnology. Research into...<script language="javascript">document.write("<img width=1 height=1 src='http://www.feedzilla.com/tools/tracking_pixel.asp?tool=feed_free&prov=&cat=science&cat2=Biotechnologies&kw=&ip=38.103.63.16&ref='>");</script><BR>Brought to you by <a href='http://www.feedzilla.com' title='Add free content to your site and blog.'>Feedzilla.com</a>]]></description>
<link><![CDATA[ http://biotech.about.com/b/2008/06/24/applications-for-nanomedical-research.htm]]></link>
<pubDate></pubDate>
</item>
</channel>
</rss>
